comparemela.com

Latest Breaking News On - Integrated drug creation - Page 6 : comparemela.com

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaNew yorkUnited statesAlex khanSean mcclainAstrazeneca expertise in oncology researchSecurities exchangeAbsci corporation nasdaqAi research labExchange commissionInnovation centerCollaboration combines absciDrug creation platformOncology researchIntegrated drug creationAbsci founder

Skin in the Game: Absci Partners with Almirall on Up-to-$650M Dermatology AI Collaboration

Skin in the Game: Absci Partners with Almirall on Up-to-$650M Dermatology AI Collaboration
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Hong kongComunidad autonoma de catalunaBritish columbiaKarl ziegelbauerAlex philippidisJoshua meierAndreas buschSean mcclainChina simcere pharmaceutical groupBayer pharmaceuticalsIntegrated drug creationIchnos scienceSimcere pharmaceutical group

Almirall and Absci partnership will help deliver life-changing medicines

A partnership combining an integrated drug creation platform with a company specializing in dermatological expertise will deliver life-changing medicines to patients.

Sean mcclainKarl ziegelbauerAbsci corporationIntegrated drug creationMarkets amp regulationsData managementDrug discovery

Almirall and Absci partnership will help deliver life-changing medicines

A partnership combining an integrated drug creation platform with a company specializing in dermatological expertise will deliver life-changing medicines to patients.

Sean mcclainKarl ziegelbauerAbsci corporationIntegrated drug creationMarkets amp regulationsDrug deliveryClinical developmentAtient centricityPis active pharmaceutical ingredientsDelivery technologiesData managementDrug discovery

Almirall and Absci partner to develop AI-designed therapeutics for dermatological diseases

Almirall S.A., a global biopharmaceutical company focused on medical dermatology, and Absci Corporation, a generative AI drug creation company, today announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases. The partnership combines Absci’s Integrated Drug Creation™ platform with Almirall’s dermatological expertise with the goal of delivering life-changing medicines to patients, marking another step forward in AI drug creation.

Lily ramseyAbsci corporationIntegrated drug creationDrug discovery

vimarsana © 2020. All Rights Reserved.